Redefining Counterfeit Medicines and Updating the Legal Framework to Address Falsified Medicines: A Qualitative Policy Review

Authors

  • Imelda G. Peña, RPh, MS, DrPH Institute of Pharmaceutical Sciences, National Institutes of Health, University of the Philippines Manila; Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila https://orcid.org/0009-0000-6116-7064
  • Yolanda R. Robles, RPh, MPharm, PhD Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila https://orcid.org/0000-0002-2136-2233
  • Roderick L. Salenga, RPh, MPH Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila
  • Monet M. Loquias, RPh, MHPEd, PhD Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila
  • Francis R. Capule, RPh, MS, PhD Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila https://orcid.org/0000-0003-2468-9095
  • Bryan Paul I. Bulatao, RPh, MSP, PhD Institute of Pharmaceutical Sciences, National Institutes of Health, University of the Philippines Manila; Department of Industrial Pharmacy, College of Pharmacy, University of the Philippines Manila https://orcid.org/0000-0002-5436-8447
  • Jean Flor C. Casauay, RPh, MSP Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila https://orcid.org/0000-0002-9095-8786

DOI:

https://doi.org/10.47895/

Keywords:

Philippines, drugs, medicine, counterfeit, falsified, fake, substandard, unlicensed, unregistered

Abstract

Background. The existence of counterfeit medicines has been a long-standing global public health concern. In the Philippines, Republic Act No. 8203 Section 3 provides a definition of counterfeit medicines, outlines prohibited acts, and states liabilities and penalties of concerned parties. The Philippine legal definiti on of counterfeit medicine needs to be aligned to what is widely accepted by the international community and to update its scope to prevent varied interpretations due to a mix in the categories of “counterfeit medicines.”

Objective. This qualitative narrative policy review aims to generate evidence on counterfeit and falsified medicines from grey literature and recent publications in order to propose recommendations for updating the legal framework to address specifically “falsified” medical products.

Methods. An online search was performed to identify relevant literature that discussed counterfeit medications. A review of narrative textual evidence from grey literature was conducted including extraction of data on the proliferation of fake, unregistered, and substandard medicines from published news articles and reports for the past six years. A review of published literature was also conducted to supplement findings from aforementioned reports and articles.

Results. Literature search revealed that the presence of counterfeit medicines remains prevalent in the country despite the enactment of RA 8203. Counterfeited products include over-the-counter medicines, prescription medicines, and vaccines. The classification of counterfeit medicines in grey literature, including news articles and FDA advisories, are aligned with the WHO definitions.

Conclusion. There is a clear need to update the regulatory framework on counterfeit medicines which would entail revisiting RA 8203 to amend the definition of counterfeit medicines and other related provisions in alignment with the WHO definitions.

Downloads

Published

09/30/2025

How to Cite

1.
Redefining Counterfeit Medicines and Updating the Legal Framework to Address Falsified Medicines: A Qualitative Policy Review. Acta Med Philipp [Internet]. 2025 Sep. 30 [cited 2025 Sep. 30];59(14). Available from: https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/9562

Most read articles by the same author(s)

Similar Articles

1-10 of 1347

You may also start an advanced similarity search for this article.